Navigation Links
Isis Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
Date:9/4/2013

CARLSBAD, Calif., Sept. 4, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2013 at 2:05 p.m. ET in New York, NY.

(Logo:  http://photos.prnewswire.com/prnh/20130807/LA60006LOGO)

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's website, www.isispharm.com.  A replay will be available on the Isis website within 48 hours and will be archived for a limited time.

About Isis Pharmaceuticals, Inc.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 29 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO™, in the United States for the treatment of patients with HoFH.  Genzyme is also pursuing marketing approval of KYNAMRO in other markets.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

Forward-Looking Statements
This press release includes forward-looking statements regarding Isis' business and the therapeutic potential of Isis' technologies and products in development.  Any statement describing Isis' goals, expectations, financial or other
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Immune Pharmaceuticals Inc. Presenting At The 15th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th, 2013
2. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
3. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
4. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
5. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
6. Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
7. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
8. AcelRx Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
9. Alexza Pharmaceuticals to Present at the Stifel Healthcare Conference 2013
10. Edison expands North American healthcare sector coverage with initiation of coverage on Alexza Pharmaceuticals
11. Imprimis Pharmaceuticals, Inc. Acquires Intellectual Property for Ophthalmic Compound Development Opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Fla. , Sept. 15, 2014 myMatrixx ... Steven Stanos with an expanded role that ... Dr. Stanos, a nationally recognized physiatrist and ... topics related to rehabilitation and workers, compensation, is Board ... by the American Board of Pain Medicine and subspecialty ...
(Date:9/15/2014)... PDL BioPharma, Inc. (PDL) (NASDAQ: ... September 12, 2014, regular quarterly dividend payment of $0.15 per ... of September 5, 2014, the record date. ... portfolio of patents and royalty assets, consisting primarily of ... agreements with various biotechnology and pharmaceutical companies. PDL pioneered ...
(Date:9/15/2014)... DUBLIN , Sept. 15, 2014 Research ... "The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition" ... volume covers the entirety of the clinical testing market and ... Used by Top IVD Companies For Business Planning. ... volume based on the market events of 2013 and early ...
Breaking Medicine Technology:myMatrixx Announces Expanded Role for Medical Director Steven P. Stanos, Jr., DO 2PDL BioPharma Completes Regular Quarterly Dividend Payment 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 2The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition 3
... NEW YORK, June 16, 2011 Reportlinker.com announces ... in its catalogue: US Wound ... http://www.reportlinker.com/p0555195/US-Wound-Closure-Devices-–-Market-Trend-Till-2016.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment ... provides vital market data on the wound closure ...
... New research adds to the growing body of ... thermometry provides reliable and accurate temperature readings. The ... enhancing patient outcomes conducted within a 558-bed community-based ... electronic (OE) thermometers both are reasonable options. The ...
Cached Medicine Technology:Reportlinker Adds US Wound Closure Devices - Market Trend Till 2016 2Research Led by Clinical Nurse Specialists Reconfirms Reliability of Temporal Artery Thermometry 2
(Date:9/15/2014)... Today, Zane Benefits, the #1 Online Health Benefits Solution, ... show. , According to Zane Benefits, health insurance ... make sense to choose a “one size fits all” ... employee as much as 60 percent on health insurance ... on Business , Chris Redgrave, highlights the rising costs ...
(Date:9/15/2014)... 2014 Ondine Biomedical Inc. is ... President and Chief Technology Officer, will be presenting ... (PDT) and Photodiagnosis in Clinical Practice. The 2014 ... from October 14-18, 2014 alongside the Congress of ... 13-14th, is an annual conference at which the ...
(Date:9/15/2014)... York, New York (PRWEB) September 15, 2014 ... C.R. Bard, Inc. continue to move forward in the ... Southern District of West Virginia, Bernstein Liebhard LLP reports. ... issued a Final Order on September 10th that provides ... The Order notes that none of the affected plaintiffs ...
(Date:9/15/2014)... Randy Dotinga HealthDay ... -- Patients prescribed cholesterol-lowering drugs are more likely to ... medications are cheaper generic brands, new research suggests. ... Well-known brands include Crestor, Zocor and Lipitor. Generic statins ... the risk of heart problems due to clogged arteries. ...
(Date:9/15/2014)... 12, 2014 - An estimated 8% of Americans will ... point during their lifetime. Brought on by an overwhelming ... of altered chemistry and physiology of the brain. Understanding ... one altered by PTSD is essential to developing effective ... BrainHealth at The University of Texas at Dallas published ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Featured on Zions Bank Speaking on Business 2Health News:Ondine Presenting at the 2014 International Symposium on Photodynamic Therapy and Photodiagnosis 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 2Health News:C.R. Bard Transvaginal Mesh Lawsuits Move Forward, With Issuance of New Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports 3Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 2Health News:Older Patients More Likely to Fill Prescriptions for Generic Statins: Study 3Health News:EEG study findings reveal how fear is processed in the brain 2
... It,s long been known that obesity increases diabetes risk, but ... someone carries -- and how long it,s carried -- can ... the growing number of obese children and teens who will ... researchers from the University of Michigan Health System warn in ...
... 2011) More part-time employment for surgeons, particularly retiring older ... families, may considerably reduce the surgeon shortage in the United ... September issue of the Journal of the American College ... gaining popularity among Generation X (currently ages 30 through early ...
... HealthDay Reporter , SUNDAY, Sept. 11 (HealthDay News) -- ... of Pearl Harbor still packs a psychological punch for many ... serves as the moment when a stunned young country shed ... stage with the now-iconic can-do bravado of the "Greatest Generation." ...
... The Journal of Emergency Medical Services (JEMS) today announces ... featuring first-person accounts of responders who were thrust into ... when terrorists invaded their response districts and their ... responders throughout the world, think, train, respond and live ...
... FRIDAY, Sept. 9 (HealthDay News) -- Almost half of all ... the months following the 9/11 terrorist attacks still struggle with ... Harris Interactive/HealthDay poll found. The most common ... 24 percent of those still affected, and anxiety, by 13 ...
... , ROCHESTER, Minn. -- Mayo Clinic researchers have developed a ... to combat human HIV/AIDS and other diseases. The goal is ... virus. The findings -- called fascinating and landmark by one ... Nature Methods . Feline immunodeficiency ...
Cached Medicine News:Health News:Lifetime 'Dose' of Excess Weight Linked to Diabetes Risk 2Health News:Allowing part-time surgeons may help address workforce shortage 2Health News:9/11 Left Permanent Scars on the American Psyche 2Health News:9/11 Left Permanent Scars on the American Psyche 3Health News:9/11 Left Permanent Scars on the American Psyche 4Health News:9/11 Left Permanent Scars on the American Psyche 5Health News:9/11 Left Permanent Scars on the American Psyche 6Health News:Out of the darkness 2Health News:For Many Americans, 9/11 Worries Still Dominate 2Health News:For Many Americans, 9/11 Worries Still Dominate 3Health News:Mayo Clinic teams with glowing cats against AIDS, other diseases 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: